Changes in 1994 drug cost for inpatient services.
The healthcare system is undergoing major changes in the manner in which healthcare is being delivered. These changes have affected individual institutions per se, as well as having an affect upon the cost of the drugs being administered. The comparative indices for the years 1993 and 1994 indicate that the utilization and classes of drugs being prescribed are undergoing change. Although drug cost has not increased to the same magnitude as in the past, it continues to show significant growth. Of continuing importance is the changes taking place in the classifications of drugs being used and the affect that these changes have on cost.
Mehl
B
B
Mount Sinai Medical Center, New York, NY 10029, USA.
D000043:Abstracting and Indexing; D000276:Adjuvants, Immunologic / Q000191:economics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs / Q000145:classification / Q000639:trends*; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007250:Inflation, Economic / Q000145:classification; D010607:Pharmacy Service, Hospital / Q000191:economics*; D014481:United States